These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 17547726
1. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Proudman SM, Stevens WM, Sahhar J, Celermajer D. Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726 [Abstract] [Full Text] [Related]
2. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A. Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505 [Abstract] [Full Text] [Related]
3. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG. Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379 [Abstract] [Full Text] [Related]
4. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, Remy-Jardin M, Matran R, Lambert M, Queyrel V, Morell-Dubois S, Guillevin L, Hatron PY. J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586 [Abstract] [Full Text] [Related]
5. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Wells AU, Steen V, Valentini G. Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223 [Abstract] [Full Text] [Related]
6. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH, Cacoub P, Frances C, Wechsler B, Grenier P, Piette JC. Arthritis Rheum; 2006 Jan; 54(1):184-91. PubMed ID: 16385514 [Abstract] [Full Text] [Related]
7. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. Garin MC, Highland KB, Silver RM, Strange C. J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563 [Abstract] [Full Text] [Related]
10. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR. J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320 [Abstract] [Full Text] [Related]